Pfizer, Inc. (NYSE:PFE) shares are trading higher on Tuesday after The Washington Post reported that President Donald Trump will announce a drug-pricing deal with the company.
What To Know: According to the report, Pfizer has agreed to voluntarily sell its medications through Medicaid at lower prices as part of the White House's "Most Favored Nation" initiative, which aims to match U.S. drug prices to the lowest costs paid by other wealthy nations.
